The causes and consequences of tumour evolution and heterogeneity - European Medical Journal

The causes and consequences of tumour evolution and heterogeneity

Oncology
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, reviews the emerging understanding of mutational drivers of tumour heterogeneity, including APOBEC-mediated mutagenesis, that could support the development of future therapeutic strategies.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now